Domainex awarded technology strategy board funding to support its research into a novel cancer drug
Domainex Ltd, the UK-based drug discovery company focused on speed and innovation, has been awarded a £250,000 grant by the Technology Strategy Board (TSB), the UK’s national innovation agency, to help support the development of a new drug for the treatment of several common cancers.
The path towards personalised medicine
Pharmacogenetics is the theme of this month’s edition of Drug Discovery Today Editor’s Choice. This coincides with the Drug Discovery Today special issue, ‘Pharmacogenetics and Stratified Medicine’.
With nearly every pharma company facing patent cliffs and the essential need to demonstrate cost-effectiveness, there has never been a more important time for
Getting physical in drug discovery: A contemporary perspective on solubility and hydrophobicity
The physical properties of drug molecules are frequently identified as a shortcoming of drugs in development. This article, the most highly-downloaded of Q3 2010, proposes a novel approach to the prediction of water solubility.
XML Feeds
